Last updated at 16 Aug 2024 08:17 AM
Director
DIN: 01572789
Rajendrakumar Jugraj Ranavat is currently associated with 2 companies in various capacities such as Director and Individual Subscriber. They serve as a Director at ASHTANG HOSPITAL & RESEARCH CENTRE PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 01572789.Rajendrakumar Jugraj Ranavat is currently involved in 2 different roles. Their most recent position is with ZENHANCE HEALTHCARE AND RESEARCH PRIVATE LIMITED as a Individual Subscriber. The first company Rajendrakumar Jugraj Ranavat was appointed to as a director was ASHTANG HOSPITAL & RESEARCH CENTRE PRIVATE LIMITED. Rajendrakumar Jugraj Ranavat has a status of Deactivated. Please verify the details for any specific requirements or conditions.
Rajendrakumar Jugraj Ranavat is currently associated with 2 companies in various capacities such as Director and Individual Subscriber. They serve as a Director at ASHTANG HOSPITAL & RESEARCH CENTRE PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 01572789.Rajendrakumar Jugraj Ranavat is currently involved in 2 different roles. Their most recent position is with ZENHANCE HEALTHCARE AND RESEARCH PRIVATE LIMITED as a Individual Subscriber. The first company Rajendrakumar Jugraj Ranavat was appointed to as a director was ASHTANG HOSPITAL & RESEARCH CENTRE PRIVATE LIMITED. Rajendrakumar Jugraj Ranavat has a status of Deactivated. Please verify the details for any specific requirements or conditions.
2
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (0)
3y 7m 1y 10m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| ASHTANG HOSPITAL & RESEARCH CENTRE PRIVATE LIMITED | Director | 11-Feb-2008 |
| ZENHANCE HEALTHCARE AND RESEARCH PRIVATE LIMITED | Individual Subscriber | 10-Apr-2023 |